Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers

Seema S. Sonnad, C. Daniel Mullins, Danielle Whicher, Jennifer C. Goldsack, Penny E. Mohr, Sean R. Tunis

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers'. Together they form a unique fingerprint.

Medicine & Life Sciences